首页> 外文OA文献 >Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

【2h】

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

机译：新的血管紧张素转化酶抑制剂CILAZAPRIL是否会在经皮冠状动脉血管成形术后重新狭窄？ Mercator研究结果：多中心，随机，双盲安慰剂对照试验。血合血管成形术后的多中心欧洲研究试验，以防止透冠状动脉梗阻和再狭窄（MERCOR）研究组。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 1992
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. [J] . Okamura A, Ohishi M, Rakugi H, Angiology: the Journal of Vascular Diseases . 1999,第10期

机译：血管紧张素转换酶抑制剂对经皮腔内冠状动脉成形术后再狭窄的作用的药理学分析。
2. External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind study. [J] . Fritz P, Stein U, Hasslacher C, International Journal of Radiation Oncology, Biology, Physics . 2004,第3期

机译：外部束放射疗法不能预防或股pop经皮腔内血管成形术后的再狭窄：一项前瞻性随机双盲研究的结果。
3. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. [J] . Park SW, Kim YH, Yun SC, Journal of the American College of Cardiology . 2011,第11期

机译：三重抗血小板治疗与双重抗血小板治疗减少长期冠状动脉病变药物洗脱支架植入后再狭窄的随机，双盲，多中心比较研究：DECLARE-LONG II（药物洗脱支架置入，西洛他唑治疗后减少晚期）的结果长期冠状动脉病变患者的再狭窄）试验。
4. Study the restenosis after Percutaneous transluminal coronary angioplasty(PTCA) in the organ culture system [C] . Zhao Ansha, Zhang Haiyan, Chen Jun Ying, International Conference on Multifunctional Materials and Structures . 2008

机译：在器官培养系统中术后经皮冠状动脉血管成形术（PTCA）后的再狭窄研究
5. Genetic Polymorphism of Angiotensin Converting Enzyme and Risk of Coronary Restenosis after Percutaneous Transluminal Coronary Angioplasties: Evidence from 33 Cohort Studies [O] . Shen Wang, Yuxiang Dai, Lingling Chen, -1

机译：血管紧张素转换酶的遗传多态性和经皮腔内冠状动脉成形术后冠状动脉再狭窄的风险：来自33个队列研究的证据
6. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group [O] . Hermans W. R., Rensing B. J., Foley D. P., 1993

机译：患者，病变和手术变量是成功进行冠状动脉成形术后腔狭窄再次狭窄的危险因素：对653例778个病变患者的定量分析。预防性腔内冠状动脉阻塞和再狭窄的血管成形术后西拉普利的多中心欧洲研究试验（MERCATOR）研究组

著录项

引文网络

相似文献

相关主题

期刊订阅